RSS-Feed abonnieren
DOI: 10.1055/s-0038-1648191
Stimulation of Tissue-Type Plasminogen Activator Synthesis by Retinoids in Cultured Human Endothelial Cells and Rat Tissues In Vivo
Publikationsverlauf
Received 12. Oktober 1990
Accepted after revision 22. Januar 1991
Publikationsdatum:
24. Juli 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199105/lookinside/thumbnails/10-1055-s-0038-1648191-1.jpg)
Summary
Tissue-type plasminogen activator (t-PA) and its inhibitor, plasminogen activator inhibitor 1 (PAI-1), play an important role in regulating the fibrinolytic capacity of plasma. Both t-PA and PAI-1 are synthesized by the endothelium. We report that retinoic acid (vitamin A acid) and other retinoids rather specifically stimulate the production of t-PA by cultured human umbilical vein endothelial cells. Effective retinoids induced a dose-dependent (range: 0.01-50 μM) increase in the production of t-PA of maximally about six-fold, while simultaneously causing no or only a small increase (less than two-fold) of PAI-1. The effects on t-PA synthesis were apparent by 4-8 h, and reached maximal values after about 24-48 h of incubation with retinoid. The retinoid effect on t-PA production was accompanied by increased t-PA mRNA levels, without any parallel change in PAI-1 or GAPDH mRNA concentrations. The study also shows that modifications at the carboxyl group of retinoic acid are associated with a decrease in stimulatory potency. The stimulatory pathway appears to be identical for all retinoids but distinct from a pathway by which another strong inducer, sodium butyrate, induces t-PA synthesis in endothelial cells. The induction of t-PA by retinoids might involve protein kinase C (PKC) as judged by an experiment using a specific PKC inhibitor.
The effect of retinoids on the fibrinolytic system in vivo was assessed by feeding rats with a vitamin A deficient diet or a diet with excess of vitamin A or other retinoids. The activity and antigen levels for t-PA in plasma and tissue samples were strongly decreased in vitamin A-starved animals, and enhanced in retinoid-fed animals. The recognition of a class of compounds, the retinoids, that can increase t-PA synthesis in cultured human endothelial cells and in rat tissues in vivo, may be of importance in designing an effective method to enhance plasma fibrinolytic activity, and thereby in preventing thrombotic phenomena.
-
References
- 1 Wun T-C, Capuano A. Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro. J Biol Chem 1985; 260: 5061-5066
- 2 Emeis JJ. Mechanisms involved in short-term changes in blood levels of t-PA. In: Tissue-type Plasminogen Activator (t-PA). Physiological and Clinical Aspects Kluft C. (Ed) CRC Press; Boca Raton, CA: 1988. vol II: pp 21-35
- 3 Kooistra T. The use of cultured human endothelial cells and hepatocy-tes as an in vitro model system to study modulation of endogenous fibrinolysis. Fibrinolysis 1990; 4 suppl (Suppl. 02) 33-39
- 4 Kooistra T, Van den Berg J, Tons A, Platenburg G, Rijken DC, Van den Berg E. Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells. Biochem J 1987; 247: 605-612
- 5 Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 1982; 42: 65-82
- 6 Kyritsis A, Joseph G, Chader GJ. Effects of butyrate, retinol, and retinoic acid on human Y-79 retinoblastoma cells growing in monolayer cultures. J Nat Cancer Inst 1984; 73: 649-654
- 7 Leftwich JA, Hall RE. Enhancement of phorbol diester-induced HL-60-mediated cytotoxicity by retinoic acid, dimethyl sulfoxide, and 5-azacytidine. Cancer Res 1986; 46: 3789-3792
- 8 Bijman JTh, Wagener DJTh, Van Rennes H, Wessels JMC, Ramaekers FCS, Van den Broek R. Modulation of placental alkaline phosphatase activity and cytokeratins in human HN-1 cells by butyrate, retinoic acid, catecholamines and histamine. Br J Cancer 1987; 56: 127-132
- 9 Malik H, Nordenberg J, Novogrodsky A, Fuchs A, Malik Z. Chemical inducers of differentiation, dimethylsulfoxide, butyric acid, and dimethylthiourea, induce selective ultrastructural patterns in B16 melanoma cells. Bio Cell 1987; 60: 33-40
- 10 Nelson NF, Cieplak W, Dacus SC, Prager MD. Modulation of secreted plasminogen activator activity of human renal carcinoma cells by dimethylsulfoxide, butyrate and retinoate. Cancer Lett 1987; 34: 305-316
- 11 Meyskens Jr FL, Goodman GE, Alberts DS. 13-Cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer. CRC Crit Rev Oncol Hematol 1985; 3: 75-101
- 12 Kluft C, Van Wezel AL, Van der Velden CAM, Emeis JJ, Verheijen JH, Wijngaards G. Large-scale production of extrinsic (tissue-type) plasminogen activator from human melanoma cells. In: Advances in Biotechnological Processes Mizrahi A, Van Wezel AL. (eds) Alan R. Liss Inc; New York: 1983. pp 97-110
- 13 Gaffney PJ, Curtis AD. A collaborative study of a proposed international standard for tissue plasminogen activator (t-PA). Thromb Haemostas 1985; 53: 134-136
- 14 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical cord veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756
- 15 Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc Natl Acad Sci USA 1979; 76: 5674-5678
- 16 Van Hinsbergh VWM, Havekes L, Emeis JJ, Van Corven E, Scheffer M. Low density lipoprotein metabolism by endothelial cells from human umbilical cord arteries and veins. Arteriosclerosis 1983; 3: 547-559
- 17 Hollander CF. Current experience using the laboratory rat in aging studies. Lab Animal Sci 1976; 26: 320-328
- 18 Padrö T, Van den Hoogen CM, Emeis JJ. Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissues. Blood Coag Fibrinol 1990; 1: 601-608
- 19 Verheijen JH, Mullaart E, Chang GTG, Kluft C, Wijngaards GA. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1982; 48: 266-269
- 20 Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
- 21 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
- 22 Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory 1982. ISBN 0-87969-136-0
- 23 Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984; 81: 1991-1995
- 24 Van Zonneveld AJ, Chang GTG, Van den Berg J, Kooistra T, Verheijen JH, Pannekoek H, Kluft C. Quantification of tissue-type plasminogen activator (t-PA) mRNA in human endothelial-cell cultures by hybridization with a t-PA cDNA probe. Biochem J 1986; 235: 385-390
- 25 Van den Berg EA, Sprengers ED, Jaye M, Burgess W, Maciag T, Van Hinsbergh VWM. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells. Thromb Haemostas 1988; 60: 63-67
- 26 Fort P, Marty L, Piechaczyk M, El Sabrouty S, Dani C, Jeanteur P, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucl Acid Res 1985; 13: 1431-1442
- 27 Offringa R, Smits AMM, Houweling A, Bos JL, Van der Eb AJ. Similar effects of adenovirus E1A and glucocorticoid hormones on the expression of the metallo-protease stromelysin. Nucl Acid Res 1988; 16: 10973-10984
- 28 Levin EG. Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells. Blood 1986; 67: 1309-1313
- 29 Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thromb Haemostas 1988; 60: 491-494
- 30 Ohkubo S, Yamada E, Eudo T, Itok H, Hidaka H. Vitamin A induced activation of Ca2+-activated, phospholipid-dependent protein kinase (“C” kinase). Biochem Biophys Res Commun 1983; 114: 1194-1199
- 31 Zylber-Katz E, Glazer RI. Phospholipid Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60. Cancer Res 1985; 45: 5159-5164
- 32 Isakov N. Regulation of T-cell-derived protein kinase C activity by vitamin A derivatives. Cell Immunol 1988; 115: 288-298
- 33 Levin EG, Marotti KR, Santell L. Protein kinase C and the stimulation of tissue plasminogen activator release from human endothelial cells. Dependence on the elevation of messenger RNA. J Biol Chem 1989; 264: 16030-16036
- 34 Inada Y, Hagiwara H, Kojima S, Shimonaka M, Saito Y. Synergism of vitamins A and C on fibrinolysis. Biochem Biophys Res Commun 1985; 130: 182-187
- 35 Kooistra T, Hendriks HFJ, Emeis JJ. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo. Fibrinolysis 1990; 4 (suppl) (Suppl. 03) 126
- 36 Thompson EA, Van Nuffelen A, Nelles L, Collen D. Stimulation of human tissue-type plasminogen activator (t-PA) synthesis by retinoic acid. Role of protein kinase C and of t-PA genomic elements. Fibrinolysis 1990; 4 (suppl) (Suppl. 03) 163
- 37 Strickland S, Breitman TR, Frickel F, Nuerrenbach A, Haedicke E, Spom MB. Structure-activity relationship of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. Cancer Res 1983; 43: 5268-5272
- 38 Tobler A, Dawson MI, Koeffler HP. Retinoids. Structure-function relationship in normal and leukemic hematopoiesis in vitro. J Clin Invest 1986; 78: 303-309
- 39 Wilson EL, Francis GE. Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells. J Exp Med 1987; 165: 1609-1623
- 40 Rickies RJ, Darrow AL, Strickland S. Differentiation-responsive elements in the 5’ region of the mouse tissue plasminogen activator gene confer two-stage regulation by retinoic acid and cyclic AMP in teratocarcinoma cells. Mol Cell Biol 1989; 9: 1691-1704
- 41 Yukioka M, Sasaki S, Le Qi S, Inova A. Two species of histone acetyltransferase in rat liver nuclei. J Biol Chem 1984; 259: 8372-8377
- 42 Chytil F. Retinoic acid: biochemistry, pharmacology, toxicology, and therapeutic use. Pharmac Rev 1984; 36: 939-1005
- 43 Maden M, Ong DE, Summerbell D, Chytil F. Spatial distribution of cellular protein binding to retinoic acid in the chick limb bud. Nature (London) 1988; 335: 733-735
- 44 Chytil F, Ong DE. Cellular retinoid-binding proteins. In: The Retinoids Spom BM, Roberts AB, Goodman DS. (eds) Academic Press; New York: 1984. Vol 2, Chapter 9, pp 89-123
- 45 Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889-895
- 46 Green S, Chambon P. Nuclear receptors enhance our understanding of transcription regulation. TIG 1988; 4: 309-314
- 47 Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (London) 1987; 330: 444-450
- 48 Brand N, Petkovich M, Krust A, Chambon P, De Thé H, Marchio A, Tiollais P, Dejean A. Identification of a second human retinoic acid receptor. Nature (London) 1988; 332: 850-853
- 49 Krust A, Kastner Ph, Petkovich M, Zelent A, Chambon P. A third human retinoic acid receptor, hRAR-γ. Proc Natl Acad Sci USA 1989; 86: 5310-5314